Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 AUD | 0.00% | +6.25% | -51.43% |
22/05 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
20/05 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.43% | 96.97L | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.21% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Limited Announces Earnings Results for the Period from 2 February to 30 June 2020